142 related articles for article (PubMed ID: 23873110)
1. Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis.
Wu D; Jiang H; Yu H; Xu D; Liang J; Jin J
Tumour Biol; 2013 Dec; 34(6):3865-9. PubMed ID: 23873110
[TBL] [Abstract][Full Text] [Related]
2. Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.
Tian X; Tian Y; Ma P; Sui C; Meng F; Li Y; Fu L; Jiang T; Wang Y; Jiang Y
Tumour Biol; 2013 Oct; 34(5):2589-97. PubMed ID: 23749486
[TBL] [Abstract][Full Text] [Related]
3. Significant associations between X-ray repair cross-complementing group 3 genetic polymorphisms and thyroid cancer risk.
Yu XL; Liu H; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG; Cai J
Tumour Biol; 2014 Mar; 35(3):2009-15. PubMed ID: 24277376
[TBL] [Abstract][Full Text] [Related]
4. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun H; Han B; Zhai H; Cheng X; Ma K
Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
[TBL] [Abstract][Full Text] [Related]
5. DNA repair gene XRCC3 T241M polymorphism and susceptibility to hepatocellular carcinoma in a Chinese population: a meta-analysis.
Ji RB; Qian YS; Hu AR; Hu YR
Genet Mol Res; 2015 Dec; 14(4):15988-96. PubMed ID: 26662391
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive assessment of the association between DNA repair gene XRCC3 rs861539 C/T polymorphism and lung cancer risk.
Ding G; Xu W; Hua H; Huang Q; Liang H; Ni Y; Ding Z
Tumour Biol; 2013 Oct; 34(5):2521-7. PubMed ID: 23982880
[TBL] [Abstract][Full Text] [Related]
7. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
Duan C; Zhang W; Lu J; Wu H; Liu M; Zhu W
Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the association between XRCC3 C18607T polymorphism and glioma risk.
Wang R; Li M; Gao WW; Gu Y; Guo Y; Wang G; Tian HL
Tumour Biol; 2014 Feb; 35(2):1101-5. PubMed ID: 24186073
[TBL] [Abstract][Full Text] [Related]
9. Association between XRCC3 Thr241Met polymorphism and risk of gynecological malignancies: A meta-analysis.
Yu X; Wang Q; He G; Yu H
Cancer Genet; 2021 Jun; 254-255():11-17. PubMed ID: 33515810
[TBL] [Abstract][Full Text] [Related]
10. XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese.
Liu C; Wang H
Tumour Biol; 2013 Aug; 34(4):2249-54. PubMed ID: 23558966
[TBL] [Abstract][Full Text] [Related]
11. XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis.
Yan Y; Liang H; Li R; Xie L; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):2711-5. PubMed ID: 24254304
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
13. XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis.
Chen X; Wang Z; Yan Y; Li P; Yang Z; Qin L; Mo W
PLoS One; 2014; 9(1):e84195. PubMed ID: 24454720
[TBL] [Abstract][Full Text] [Related]
14. Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis.
Yan Y; Liang H; Li T; Guo S; Li M; Qin X; Li S
Leuk Lymphoma; 2014 Sep; 55(9):2130-4. PubMed ID: 24304418
[TBL] [Abstract][Full Text] [Related]
15. DNA repair gene XRCC3 polymorphisms and bladder cancer risk: a meta-analysis.
Peng Q; Mo C; Tang W; Chen Z; Li R; Zhai L; Yang S; Wu J; Sui J; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1933-44. PubMed ID: 24104500
[TBL] [Abstract][Full Text] [Related]
16. XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis.
Zhan P; Wang Q; Qian Q; Yu LK
J Exp Clin Cancer Res; 2013 Jan; 32(1):1. PubMed ID: 23289442
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms of XRCC3 gene in hepatocellular carcinoma - relationship with clinicopathological features.
Avadanei ER; Giusca SE; Negura L; Caruntu ID
Pol J Pathol; 2018; 69(1):73-81. PubMed ID: 29895130
[TBL] [Abstract][Full Text] [Related]
18. Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population.
Luo HC; Zhang HB; Xin XJ; Huang WX
Tumour Biol; 2014 Apr; 35(4):3415-9. PubMed ID: 24307625
[TBL] [Abstract][Full Text] [Related]
19. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
20. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
